![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 12, 10162-10173, March 21, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Bovine and human lactoferrins (LF) prevent
hepatitis C virus (HCV) infection in cultured human hepatocytes; the
preventive mechanism is thought to be the direct interaction between LF
and HCV. To clarify this hypothesis, we have characterized the binding activity of LF to HCV E2 envelope protein and have endeavored to
determine which region(s) of LF are important for this binding activity. Several regions of human LF have been expressed and purified
as thioredoxin-fused proteins in Escherichia coli.
Far-Western blot analysis using these LF fragments and the E2 protein,
expressed in Chinese hamster ovary cells, revealed that the 93 carboxyl amino acids of LF specifically bound to the E2 protein. The 93 carboxyl
amino acids of LFs derived from bovine and horse cells also possessed
similar binding activity to the E2 protein. In addition, the amino acid
sequences of these carboxyl regions appeared to show partial homology
to CD81, a candidate receptor for HCV, and the binding activity of
these carboxyl regions was also comparable with that of CD81. Further
deletion analysis identified 33 amino acid residues as the minimum
binding site in the carboxyl region of LF, and the binding specificity
of these 33 amino acids was also confirmed by using 33 maltose-binding
protein-fused amino acids. Furthermore, we demonstrated that the 33 maltose-binding protein-fused amino acids prevented HCV infection in
cultured human hepatocytes. In addition, the site-directed mutagenesis to an Ala residue in both terminal residues of the 33 amino acids revealed that Cys at amino acid 628 was determined to be critical for
binding to the E2 protein. These results led us to consider the
development of an effective anti-HCV peptide. This is the first
identification of a natural protein-derived peptide that specifically
binds to HCV E2 protein and prevents HCV infection.
Identification of a Lactoferrin-derived Peptide Possessing
Binding Activity to Hepatitis C Virus E2 Envelope Protein*
,
¶,
,
,
**
Department of Molecular Biology, Okayama
University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan, § Gastroenterological Center, Yokohama City
University Medical Center, Yokohama City University School of Medicine,
Yokohama 236-0004, Japan, and
Department of Pediatrics, Tsukuba
University School of Medicine, Tsukuba 305-8575, Japan
*
This work was supported by grants-in-aid for the
Second-Term Comprehensive 10-Year Strategy for Cancer Control
and for research on hepatitis and BSE from the Ministry of Health,
Labor and Welfare and by grants-in-aid for scientific research from the
Organization for Pharmaceutical Safety and Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
K. Naka, K. Takemoto, K.-i. Abe, H. Dansako, M. Ikeda, K. Shimotohno, and N. Kato Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors J. Gen. Virol., October 1, 2005; 86(10): 2787 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Isaacs Human Milk Inactivates Pathogens Individually, Additively, and Synergistically J. Nutr., May 1, 2005; 135(5): 1286 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Oho, F. J. Bikker, A. V. Nieuw Amerongen, and J. Groenink A Peptide Domain of Bovine Milk Lactoferrin Inhibits the Interaction between Streptococcal Surface Protein Antigen and a Salivary Agglutinin Peptide Domain Infect. Immun., October 1, 2004; 72(10): 6181 - 6184. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |